Angion Biomedica Corp. (ANGN) stock declined over -2.48% intraday to trade at $1.97 a share on NASDAQ. The stock opened with a gain of 35.86% at $1.9 and touched an intraday high of $2, falling -2.48% against the last close of $2.02. The stock went to a low of $1.81 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue28.31 Million
5Y Sales Change-
Fiscal Year Ends2021-12-30
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3777, a hepatocyte growth factor mimetic for acute kidney injury, acute lung injury, acute respiratory distress syndrome, central nervous system injuries, and heart injuries. It also develops ANG-3070, a tyrosine kinase inhibitor and rho kinase 2 inhibitors for fibrotic diseases; and CYP11B2, an aldosterone synthase inhibitor for aldosterone-related fibrotic diseases. The company was incorporated in 1998 and is based in Uniondale, New York.
Angion Biomedica Corp. (NASDAQ: ANGN) stock price is $1.97 as of the last check on Thursday, June 23. During the trading session, ANGN stock reached the peak price of $2 while $1.81 was the lowest point it dropped to.
The NASDAQ listed ANGN is part of Pharmaceuticals industry that operates in the broader Health Care sector. Angion Biomedica Corp. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases.
Dr. Jay R. Venkatesan M.B.A., M.D., Ph.D.
Pres, CEO & Director
Mr. Gregory S. Curhan
Interim Chief Financial Officer
Ms. Jennifer J. Rhodes J.D.
Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec.
Dr. Itzhak D. Goldberg
Exec. Chairman & Chief Scientific Officer
ANGN stock traded closed the last session at $1.97, which is $-0.05 or -2.48% lower than its previous close of $2.02. ANGN's current trading price is 83.26% lower than its 52-week high of $15.56 where as its distance from 52-week low of 1.08% is -87.34%.
Number of ANGN employees currently stands at -. ANGN operates from 51 Charles Lindbergh Boulevard, Uniondale, NY 11553, United States.
Official Webiste of $ANGN is: https://www.angion.com
ANGN stock volume for the day was 433,354 shares while in the previous session number of ANGN shares traded was 433,400 . The average number of ANGN shares traded daily for last 3 months was 113.5 Thousands.
The percentage change in ANGN stock occurred in the recent session was -2.48% while the dollar amount for the price change in ANGN stock was $-0.05.
In the recent session, the day high for ANGN stock was $2 while the low for ANGN stock touched on the day was $1.81.
The market value of ANGN currently stands at 55.53 Million with its latest stock price at $1.97 and 29.96 Million of its shares outstanding.